Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Laryngoscope Investig Otolaryngol ; 5(6): 1184-1191, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-33364411

RESUMEN

Beginning in the late 20th century, implantable hearing aids were developed and used as an alternative for individuals who were unable to tolerate conventional hearing aids. Since that time, several devices have been developed, with four currently remaining on the international market (Med-el Vibrant Soundbridge, Envoy Esteem, Ototronix MAXUM, and Cochlear Carina). This review will briefly examine the history of middle ear implant development, describe current available devices, evaluate the benefits and limits of the technology, and consider the future directions of research in the field of implantable hearing aids.

2.
Otolaryngol Clin North Am ; 52(2): 297-309, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-30770176

RESUMEN

The Envoy Esteem and the Carina system are the 2 totally implantable hearing devices. The Esteem is designed for patients with bilateral moderate to severe sensorineural hearing loss who have an unaided speech discrimination score of greater than and equal to 40%. The Carina system is designed for patients with moderate to severe sensorineural hearing loss or those with mixed hearing loss. The Esteem offers a technologically advanced method to provide improvements in hearing and is available in the United States, whereas the Carina system is currently not available in the United States.


Asunto(s)
Pérdida Auditiva Sensorineural/cirugía , Prótesis Osicular , Audífonos , Humanos , Diseño de Prótesis , Implantación de Prótesis , Estados Unidos
3.
Otolaryngol Clin North Am ; 47(6): 941-52, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25256656

RESUMEN

This article discusses the Envoy Esteem implantable hearing system, a completely implantable hearing device. The device is indicated for patients older than 18 years with stable moderate to severe sensorineural hearing loss and good speech discrimination. The device is placed through an intact canal wall tympanomastoidectomy with a wide facial recess approach. The implant is typically activated at 6 to 8 weeks postoperatively and usually requires several adjustments for optimal performance. The sound processor/battery lasts 4.5 to 9.0 years and can be replaced through a minor outpatient procedure.


Asunto(s)
Audífonos , Pérdida Auditiva Sensorineural/terapia , Prótesis Osicular , Diseño de Prótesis , Implantación de Prótesis/métodos , Adulto , Anciano , Humanos , Persona de Mediana Edad , Adulto Joven
4.
Indian J Otolaryngol Head Neck Surg ; 61(3): 245-51, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23120645

RESUMEN

Hearing aids are the principal means of auditory rehabilitation for patients with moderate to severe sensorineural hearing loss. Although technical improvements and modifications have improved the fidelity of conventional aids, hearing aids still have many limitations. Implantable hearing aids offer patients with hearing loss several potential advantages over conventional hearing aids. This presentation will highlight our first experience, the indications, the procedure, the advantages and the current status of totally implantable hearing aids.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA